Ion-activated mucoadhesive in situ gel incorporating terbinafine-loaded NLCs promotes ocular penetration and retention for enhanced fungal keratitis therapy
Source abstract
Abstract
Fungal keratitis (FK) is a sight-threatening infection with poor outcomes due to rapid tear clearance and insufficient corneal penetration. To overcome the limitations, we developed an ion-activated mucoadhesive in-situ gelling system (TH-NLC-ISG) integrating terbinafine-loaded nanostructured lipid carrier (TH-NLC) into a gellan gum/carboxymethyl chitosan matrix. The optimized formulation exhibited a particle size of 25.27 ± 0.75 nm. Upon contact with simulated tear fluid, the formulation underwent rapid sol-gel transition, achieving a 70-fold viscosity increase (34°C, shear rate 1 s -1 ), critical for prolonged ocular residence. Fluorescence imaging demonstrated ocular retention of fluorescein sodium-labeled TH-NLC-ISG exceeding 60 min, significantly longer than the non-gelling control. In vivo pharmacokinetic studies revealed markedly improved ocular bioavailability, with higher area under the concentration in ocular tissues-time curve of TH in the TH-NLC-ISG group compared to TH-NLC. Corneal penetration studies confirmed that TH-NLC-ISG exhibited longer corneal retention time and higher corneal drug retention compared to TH-NLC. The formulation demonstrated excellent ocular biocompatibility in vitro and in vivo . TH-NLC-ISG exhibited potent in vitro antifungal activity against Fusarium solani. and Aspergillus flavus. , with a lower MIC 50 value than TH suspension. In rabbits and mice FK models, TH-NLC-ISG group achieved complete corneal healing, reduced clinical scores and corneal perforation rates, displaying efficacy superior to conventional natamycin eye drops. By synergistically augmenting retention and corneal permeation, TH-NLC-ISG provides a transformative strategy for enhanced fungal keratitis therapy. • An innovative ion-activated in situ gelling system integrating nanostructured lipid carriers (NLCs) into a gellan gum/carboxymethyl chitosan (GG/CMCS) matrix was engineered. • The formulation utilizes an ion-triggered sol-gel transition (70-fold viscosity increase) and electrostatic mucoadhesion to overcome rapid tear clearance. • Synergy between NLCs (penetration) and smart hydrogel (retention) significantly enhanced ocular bioavailability and corneal drug retention. • The therapeutic platform demonstrated superior efficacy over commercial natamycin in resolving fungal keratitis in animal models.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Ocular Surface and Contact Lens · Advancements in Transdermal Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Six-year analysis of the pathogenic spectrum, risk factors, and prognosis of non-traumatic fungal keratitis in Northern China10.1111/ceo.14314 ↗
2. Fungal keratitis: a review of clinical presentations, treatment strategies and outcomes10.1016/j.jtos.2021.12.001 ↗
3. The global incidence and diagnosis of fungal keratitis10.1016/S1473-3099(20)30448-5 ↗
4. Mycotic Keratitis-A global threat from the filamentous fungi10.3390/jof7040273 ↗
5. Trans-corneal drug delivery strategies in the treatment of ocular diseases10.1016/j.addr.2023.114868 ↗
6. Topical ocular drug delivery systems: innovations for an unmet need10.1016/j.exer.2022.109006 ↗
7. Ocular drug delivery: present innovations and future challenges10.1124/jpet.119.256933 ↗
8. Recent progress of solid lipid nanoparticles and nanostructured lipid carriers as ocular drug delivery platforms10.3390/ph16030474 ↗
9. In situ gelling systems for ocular drug delivery10.1016/j.jconrel.2024.05.031 ↗
10. Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations10.1007/s11051-020-04848-0 ↗
11. The effect of charges on the corneal penetration of solid lipid nanoparticles loaded Econazole after topical administration in rabbits10.1016/j.ejps.2023.106494 ↗
12. Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development, in-vitro and in vivo study10.1080/10717544.2022.2048134 ↗
13. Dasatinib and erianin co-loaded ion-responsive in-situ hydrogel for effective treatment of corneal neovascularization10.1016/j.jconrel.2024.10.001 ↗
14. Formulation and evaluation of nano lipid carrier-based ocular gel system: optimization to antibacterial activity10.3390/gels8050255 ↗
15. Potential of vB_Pa_ZCPS1 phage embedded in situ gelling formulations as an ocular delivery system to attenuate Pseudomonas aeruginosa keratitis in a rabbit model10.1016/j.jconrel.2025.01.091 ↗
16. A stemness‐enhanced eye drop stimulates corneal regeneration via sustained release of versican and providing lubricated substrate10.1002/adfm.202411735 ↗
17. pH sensitive in-situ gel for ophthalmic delivery of ofloxacin and dexamethasone sodium phosphate: formulation, development, and evaluation10.1016/j.matpr.2023.07.161 ↗
18. Development and characterization of dual-loaded niosomal ion-sensitive in situ gel for ocular delivery10.3390/gels10120816 ↗
19. Gellan gum-based in-situ gel formulations for ocular drug delivery: a practical approach10.1016/j.ijbiomac.2024.138979 ↗
20. Gel properties and interactions of hydrogels constructed with low acyl gellan gum and puerarin10.1016/j.carbpol.2023.121594 ↗
21. Multifunctional pH-responsive hydrogel dressings based on carboxymethyl chitosan: synthesis, characterization fostering the wound healing10.1016/j.carbpol.2024.122348 ↗
22. A dual-functional chitosan derivative platform for fungal keratitis10.1016/j.carbpol.2021.118762 ↗
23. Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis10.1016/j.ejps.2012.12.014 ↗
24. Natamycin ocular delivery: challenges and advancements in ocular therapeutics10.1007/s12325-023-02541-x ↗
25. In vitro activity of novel antifungals, natamycin, and terbinafine against Fusarium10.1128/aac.01913-24 ↗
26. Preparation, characterisation, and topical delivery of terbinafine10.3390/pharmaceutics11100548 ↗
27. In vitro and in vivo evaluation of Gelrite® gellan gum-based ocular delivery system for indomethacin
28. Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system
29. Micelle carriers based on macrogol 15 hydroxystearate for ocular delivery of terbinafine hydrochloride: in vitro characterization and in vivo permeation10.1016/j.ejps.2017.08.020 ↗
30. Assessment to the antifungal effects in vitro and the ocular pharmacokinetics of solid-lipid nanoparticle in rabbits10.2147/IJN.S340068 ↗
31. Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository10.1016/S0378-5173(97)00386-4 ↗
32. Biophilic positive carbon dot exerts antifungal activity and augments corneal permeation for fungal keratitis10.1021/acs.nanolett.4c01042 ↗
33. Novel nanomicelle butenafine formulation for ocular drug delivery against fungal keratitis: in vitro and in vivo study10.1016/j.ejps.2023.106629 ↗
34. Comparison of the different protocols of the Hen's Egg Test-Chorioallantoic Membrane (HET-CAM) by evaluating the eye irritation potential of surfactants
35. Celastrol-based nanomedicine promotes corneal allograft survival10.1186/s12951-021-01079-w ↗
36. Rabbit fungal keratitis model of Fusarium solani tested against three commercially available antifungal drugs10.1097/ICL.0000000000000689 ↗
37. Rabbit model of aspergillus keratitis induced by modified corneal surface lens method
38. Gallic acid ameliorates Aspergillus fumigatus keratitis through reducing fungal load and suppressing the inflammatory response10.1167/iovs.63.12.12 ↗
39. Experimental keratomycosis in a mouse model10.1167/iovs.02-0446 ↗
40. Solubility enhancement of terbinafine hydrochloride by hydrotropic technique
41. In vivo assembly drug delivery strategy based on ultra-small nanoparticles: toward high drug permeation and accumulation for CNV treatment10.1016/j.cej.2022.137968 ↗
42. Cubosomal lipid nanoassemblies with pH-sensitive shells created by biopolymer complexes: a synchrotron SAXS study10.1016/j.jcis.2021.08.187 ↗
43. Nanoemulsion-based pseudopolyrotaxane hydrogel for enhanced corneal bioavailability and treatment of corneal inflammation10.1016/j.jconrel.2024.12.075 ↗
44. Influence of HA on release process of anionic and cationic API incorporated into hydrophilic gel10.3390/ijms24065606 ↗
45. Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction
46. Terbinafine: mode of action and properties of the squalene epoxidase inhibition10.1111/j.1365-2133.1992.tb00001.x ↗
47. Detailed mechanism of squalene epoxidase inhibition by terbinafine10.1021/ci100403b ↗